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Abstract
Colon cancer arises due to the conversion of precancer-
ous polyps (benign) found in the inner lining of the co-
lon. Prevention is better than cure, and this is very true 
with respect to colon cancer. Various epidemiologic stud-
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ies have linked colorectal cancer with food intake. Apple 
and berry juices are widely consumed among various 
ethnicities because of their nutritious values. In this re-
view article, chemopreventive effects of these fruit juices 
against colon cancer are discussed. Studies dealing with 
bioavailability, in vitro  and in vivo  effects of apple and 
berry juices are emphasized in this article. A thorough 
literature survey indicated that various phenolic phyto-
chemicals present in these fruit juices have the innate 
potential to inhibit colon cancer cell lines. This review 
proposes the need for more preclinical evidence for the 
effects of fruit juices against different colon cancer cells, 
and also strives to facilitate clinical studies using these 
juices in humans in large trials. The conclusion of the re-
view is that these apple and berry juices will be possible 
candidates in the campaign against colon cancer.
© 2014 Baishideng Publishing Group Inc. All rights reserved.
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Core tip: Colon cancer is one of the leading causes of 
death worldwide. Chemoprevention of colon cancer us-
ing various dietary agents is an area of current interest. 
This manuscript reviews the chemopreventive potential 
of apple and berry juices against colon cancer. This 
work will further promote the importance of dietary 
fruit juices in colon cancer prevention.
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INTRODUCTION
Current statistics from the American Cancer Society indi-
cate that in 2014, there will 1665540 new cancer cases in 
the United States and 585720 cancer deaths, correspond-
ing to 1600 deaths per day. Colon cancer is the second 
most prevalent cause of  cancer death in men and women 
after lung cancer. Recently, there has been tremendous 
growth in understanding the fundamentals of  carcino-
genesis leading to the new mode of  cancer prevention 
known as “chemoprevention.” Chemoprevention is de-
fined as the intake of  foreign agents in order to restrain 
induction, to prevent or slow the progression of  cancer, 
or reversal of  carcinogenesis at a premalignant stage[1]. 
Chemoprevention makes use of  either suitable pharma-
cologic or dietary agents that are consumed in various 
forms such as macronutrients, micronutrients, or non-
nutritive phytochemicals[2]. Various dietary agents have 
been explored for their chemopreventive effects against 
cancers[3,4]. There is always an increasing interest for how 
these agents are linked with colon cancer, as unlike other 
cancer cells, colon cancer cells are exposed directly. Vari-
ous epidemiologic studies demonstrated that the oral 
consumption of  fruits and vegetables is inversely associ-
ated with the risk of  cancer development[5]. In addition, 
fruits consumed in liquid form as juices also exhibit similar 
chemopreventive effects against colon cancer[6,7]. Diges-
tive tract cancers, especially colon cancer, are amenable 
to dietary modification. Recent research works show that 
almost 75% of  all the sporadic cases of  colorectal cancer 
are directly affected by dietary intake. Thus, dietary modi-
fication is probably one of  the best ways for alleviating 
the risk of  developing colon cancer[8]. 
Apple and berry fruits have long been widely con-
sumed by various ethnicities because of  their beneficial 
values. Fruit juice intake is gaining in popularity among 
younger generations due to the comparative ease of  
consumption. Moreover, the quantity of  fruit intake can 
also be incremented by the intake of  juice. In addition to 
this, fruit juices are available in most retail stores and the 
various benefits of  intake have encouraged many to con-
sume them. The protective nature of  fruits against colon 
cancer may be attributed to the presence of  compounds 
such as dietary fiber, minerals, vitamins and phytochemi-
cals[9]. Phytochemicals are biologically active non-nutrient 
components present in fruits that can be divided into 
alkaloids, carotenoids, polyphenols and other nitrogen-
containing components[10]. The phytochemicals have a 
chemopreventive property due to their antioxidant activ-
ity via inactivation of  reactive oxygen species, which plays 
a vital role in the initiation and progression of  colon 
cancer[11]. Hence adequate intake of  these phytochemicals 
may hinder cancer by enhanced DNA repair and thereby 
reduce the damage to DNA via oxidative stress[12]. 
We recently reviewed the role of  pomegranate and 
citrus juices in colon cancer prevention[4]. As a fair 
amount of  research has been conducted using apple and 
berry juice phytochemicals as a chemopreventive agent 
against cancer, we chose to further delineate the chemo-
preventive effects of  these juices against colon cancer as 
well. For this purpose, studies examining the effects of  
apple and berry juices in colon cancer cell lines and ani-
mal models, as well as their bioavailability, are discussed. 
APPLE JUICE
The botanical name of  the apple is Malus domestica. It is 
the one of  the most commonly cultivated tree fruits. Ap-
ple juice is the consumable fluid or liquid that is obtained 
by crushing the apple. The apple juice contains various 
beneficial polyphenols such as hydroxycinnamic acids, 
flavan-3-ols/procyanidins, flavonols, dihydrochalcones, 
and anthocyanins (red peel). 
Bioavailability and metabolism of apple juice in colon 
cancer
In order to determine the protective effect of  apple juice 
on colon cancer, we first must understand the bioavail-
ability of  apple products. Research on determination 
of  absorption in ileostomy patients by Feskanich et al[13] 
showed that nearly 67%-100% of  apple phenolics were 
digested almost completely in the small intestine itself, 
while only 0%-33% reached the colon. These authors 
showed the level of  metabolization of  the polyphenolic 
components of  the apple juice after digestion and ab-
sorption. Other studies have demonstrated the extensive 
cleavage, isomerization and conjugation of  the native 
polyphenolic compounds occurring during the process. 
It was observed that 12.7% of  the cloudy apple juice 
compounds get as far as the intestine, however, 22.3% of  
the apple juice compounds are recovered as metabolites. 
These studies shed light on the importance of  the com-
pounds in the metabolized apple products and indicate 
the need for the determination of  the biologic activity of  
metabolites of  the phytochemicals in vivo[13]. In general, 
only the native polyphenolic compounds are commonly 
tested, though they are subjected to substantial metabolic 
modification. Thus, under physiologic conditions of  the 
tissues, the ingested polyphenolic compounds may be 
present in a very small quantity or absent. The ingested 
polyphenols are metabolized by colonic microflora. 
Hence, it is vital to examine the breakdown products pro-
duced at the stomach along with the various metabolites 
in the blood[13]. 
In vitro studies of apple juice using colon cancer cell 
lines
For the study of  in vitro effects of  apple juice on cancer 
related processes, various experiments were conducted 
using cultured colonic cells and cancer-derived cell lines 
at different developmental stages. Schaefer et al[14] crushed 
and extracted apple juice to obtain several polyphenolic 
mixtures from cider and table apples harvested in Ger-
many, including one extract from apple pomace. A com-
parison was made among four preparations differing in 
relative percentages of  14 phytochemicals in apple juice 
and their effects on oxidative markers in cell lines such 
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as Caco-2 and HT29. HT29 is a well-developed cell line 
of  colon adenocarcinoma and Caco-2 cells are from hu-
man colon cancer cells. It was found that all the extracts 
reduced the oxidative damage and the presence of  butyl 
hydroperoxide-induced reactive oxygen species. Even 
though there is difference in the effectiveness observed 
in the different extract preparations, their efficacy against 
cancer is similar to the efficacy of  phytochemicals identi-
fied in the apple juice. In addition, antioxidant capacity 
determined by Trolox equivalent antioxidant capacity 
differed for the various extracts with similar chemical 
compositions. This indicates that there are unknown 
compounds that account for the antioxidant effects in 
apple juice. Moreover, prolonged exposure of  apple juice 
results in even greater antioxidant properties for some 
compounds. From this, it can be deduced that metabolic 
products obtained over time may have enhanced antioxi-
dant capacity compared to the parent phytochemicals. 
A recent study examined the effect of  apple juice on 
cell proliferation. An experiment was done with MCF-7 
cells, a breast cancer cell line, and HT29 cells for the 
study of  effect of  extracts of  ten fruits, including apple 
peels[15]. Moreover, a proportion of  anthocyanidin-rich 
parts of  the fruit juices were tested. It was found that 
apple peel extract exhibited the property of  signifi-
cant dose reduction in HT29, but not MCF-7 cells; the 
MCF-7 cells were less responsive to extract exposure. 
Thus, there was a differential outcome in the inhibitory 
effect of  anthocyanidin-rich fraction of  apple juice in 
HT29 cells.
Gossé et al[16] conducted a study to determine whether 
polymeric or monomeric apple polyphenols are more 
effective in attenuating the proliferation of  SW620 
adenocarcinoma-derived metastatic colon cancer cells. 
This study revealed that larger polymeric molecules are 
absorbed in a higher segment of  the intestine, which re-
duces their effectiveness in attenuating colon cancer. The 
absorbed polymeric molecules result in increased residual 
concentration in the colon. When the SW620 cells are 
incubated with the procyanidins (polymeric molecules), 
dose-dependent inhibition of  cell growth was observed; 
50% inhibition was observed at 45 mg/mL, and total 
inhibition at 70 mg/mL. Moreover, this extract induced 
downregulation of  various signaling pathways involved 
in cell proliferation and differentiation, including protein 
kinase C (PKC), and enzymes involved in polyamine bio-
synthesis. The polyamines are regulators of  cell function 
and have a significant impact on cancer via nurturing cell 
proliferation or cell death based on the cell type. Finally, 
flow cytometric experiments revealed that the apple ex-
tract increased the number of  apoptotic cells and inter-
rupted the cell cycle. In an extension of  the above study, 
the procyanidins found in apple juice have dual effects 
of  downregulating polyamine biosynthesis and stimulat-
ing the catabolism or breakdown of  these compounds. 
In addition, the apoptotic effect of  apple procyanidins 
is improved by a compound that disables the activity of  
polyamine oxidase. Hence, the authors concluded that 
apple procyanidins are a potential chemopreventive agent 
for treating colon cancer.
Some other works have described the molecular 
mechanisms and cell signaling response to apple juice 
exposure. A recent work by Kern et al[17] in 2007 showed 
that after 24-h exposure at a high concentration (403 
mg/mL) of  apple juice, PKC activity was decreased by 
50% in HT29 cells. When the duration of  exposure was 
longer, extracts in the apple juice targeted the signaling 
elements upstream of  PKC. However, when each com-
pound was segregated from the apple extract, they were 
ineffective in altering any of  the markers under study. 
Thus, it may be concluded that only the composite mix-
ture of  the apple extracts are more important in mediat-
ing the observed effects due to the synergy or interaction 
between different compounds. 
The effects of  apple juice products on particular 
enzymes involved in colon carcinogenesis have also 
been studied. Cytochrome P450 1A1 is one of  the most 
prominent enzymes responsible for activating the chemi-
cal carcinogens in the colon. In a study using Caco-2 
cells, apple juice without or with reduced levels of  acids, 
carbohydrates, and other native compounds induced the 
expression of  cytochrome P450 1A1 as well as inhibited 
its catalytic activity. The major phenolics isolated from the 
apple juice, such as phlorizin, rutin, quercetin and their two 
glucoside forms, and phloretin, exhibited significant inhibi-
tion. It was found that the other types of  enzymes relevant 
to cancer etiology also were favorably affected by apple 
products[18]. In a study, polyphenols were extracted from 
cider apple and a variety of  juices. Moreover, an artificial 
mixture mimicking the natural polyphenolic profile was de-
veloped, and its effect on cultured HT29 cells was studied. 
Cells incubated with the apple juice extract for 24, 48, or 
72 h had a decreased growth rate. Furthermore, inhibition 
of  cell growth by the synthetic mixture was less efficient 
than the natural polyphenolic profile. The isolated com-
ponents were less effective than both mixtures. Treatment 
with apple juice triggered an increase in the expression of  
some vital genes, which includes phase 2 enzymes. These 
enzymes are associated with chemoprevention (glutathione 
S-transferases and sulfotransferases). Even though more 
study is needed, it is intriguing that the apple products have 
the potential to alter the genetic profiles in a protective 
manner. All the observed results clearly show that individu-
al isolated components are less effective than the complete 
mixture of  the juice polyphenols. 
In 2007, Veeriah et al[19] examined the effects of  apple 
extracts fermented in vitro with human fecal flora on cul-
tured HT29 and LT97 cells. LT97 is a colon adenoma cell 
line representing the early stage of  malignant tumor de-
velopment. It was found that 99.9% of  the parent poly-
phenols, with the exception of  complex structures, were 
degraded due to fecal fermentation. Furthermore, the 
short-chain fatty acids (SCFA) increased 1.5-fold in the 
fermented samples compared to non-fermented samples. 
Even though a correlation between growth inhibition and 
SCFA was not assessed, it is known that SCFA stimulates 
apoptosis, differentiation, and growth arrest pathways. 
Hence, it can be concluded that the fermented apple juice 
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Berry juices are prepared by crushing various berries and 
bottled for marketing.
Bioavailability and metabolism of berry juice in colon 
cancer
Anthocyanins in chokeberry extract pass into the large 
intestine and are degraded by bacteria. Detecting and 
measuring the trace levels of  anthocyanins in urine, 
plasma, excretion and metabolism is very difficult[24]. 
Approximately 66% of  anthocyanins derived from 
cyanidine-3-galactoside were detected in urine and serum 
samples of  volunteers who consumed 20 g of  choke-
berry extract consisting of  1.3 g cyanidin-3-glycosides. 
Metabolites such as oxidized and methylated derivatives 
of  cyanidin-3-galactoside, cyanidin glucuronide and 
glucuronide conjugates, were present at levels of  0.011 
to 0.013 nmol/L in urine samples. The cumulative total 
serum concentration of  anthocyanins and their metabo-
lites was 591.7 nmol/L[25]. Wu et al[26] reported similar 
results, showing that cyanidine-3-galactoside accounted 
for 60.7% of  the total anthocyanin-based compounds in 
the urinary excretion of  chokeberry-fed pigs. The peak 
anthocyanin concentration of  2.9 nmol/L in plasma at 1 
h and 18 min, including a total renal excretion of  0.02% 
of  ingested anthocyanins over 24 h, which are metabo-
lites of  cyanidin, was observed in healthy volunteers as 
depicted by Wiczkowski et al[27] in 2010. As flavonols are 
present in very small quantities in chokeberry extracts, 
there is not much information on its bioavailability. How-
ever, a study with rats by Kida et al[28] in 2000 showed that 
the monomers of  flavan-3-ol were eliminated in the liver 
from the bloodstream and returned to the small intestine. 
Flavan-3-ols are highly excreted in urine and recovered in 
ileal fluid from ileostomy patients[29]. Biosorption studies 
revealed that biologic uptake of  anthocyanin extracts de-
pends on the structure of  anthocyanin. However, Koide 
et al[30] demonstrated that HCT-15 cancer cell growth in-
hibition was affected by various anthocyanin sources and 
glycosylation modifications. In addition, anthocyanins in 
bilberry extracts are non-acylated glucoside derivatives, 
but are cyanidin derivatives in chokeberry extracts. 
In vitro studies of berry juice using colon cancer cell 
lines
Growth of  human intestinal carcinoma HCT-15 cells 
in vitro was inhibited efficaciously by anthocyanin frac-
tions extracted from different cherry and berry extracts 
in comparison to that of  flavonoid fractions[31]. Berry 
extracts including cowberry, strawberry, blueberry, and 
bilberry extracts that contain anthocyanins inhibited the 
growth of  HCT-116 colon cancer cells[32]. Growth of  
HT29 and HCT-116 cell lines were also inhibited by tart 
cherry anthocyanins and their aglycon, cyanidin[33]. Cyani-
din-3-galactoside is the predominant anthocyanin in com-
mercialized chokeberry ARE that is available as a mixture 
of  phenolic compounds. Chokeberry AREs rendered 
65% growth inhibition and cell viability of  HT29 cells 
within 24 h of  exposure, suggesting a cytostatic inhibi-
extracts have an antiproliferative effect on both types of  
cells lines, especially LT97 cells. 
In vivo effect of apple juice on colon cancer
To determine the impact of  apple juice on colon cancer, 
Barth et al[20] utilized a rat model of  chemically induced 
colonic damage (using 1,2-dimethylhydrazine). The rats 
were fed daily with two preparations of  apple juice, a clear 
juice preparation and “cloudy” (higher content of  pectin 
and procyanidin) preparation, obtained from a combina-
tion of  apples, for seven weeks. The daily consumption 
of  this apple juice protected the mucosa from colonic 
damage. As there is a possibility for the progression of  
early lesions into malignancies, the presence of  hyper-
proliferative and aberrant crypts indicated the potential 
pathogenesis in this rat model. The two methods of  apple 
juice preparation decreased the number of  large aberrant 
crypt foci in the distal colon, DNA damage and hyperpro-
liferation. The same authors further studied the effects of  
segregated fractions on the various markers and conclud-
ed that the juice in the original form has a better efficacy 
compared to the unique components, which include the 
polyphenolic-rich extracts[21]. The work done by Soyalan et 
al[22] demonstrated the potential of  polyphenol-rich apple 
juices in stimulating the redox-sensitive gene expression in 
rats for colon cancer prevention. They also elucidated that 
the cloudy apple juice has better efficacy as a cancer che-
mopreventive agent compared to the clear apple juice and 
smoothie apple juice. In another independent experiment, 
Koch et al[23] explored the efficacy of  apple juice in obese 
rats, and found no cancer preventive bioactivity. Although 
obesity and colon cancer formation are directly linked, 
they did not rule out the role of  chemopreventive effects 
of  apple juices and suggested future trials with obese or 
diabetic human individuals[23]. 
In another study, rats were injected with the chemi-
cal carcinogen azoxymethane, which results in various 
morphologic changes such as carcinoma. It was found 
that apple extracts given along with the animals’ drinking 
water for 6 wk had colon cancer protective effects[16]. Pre-
neoplastic lesions in the rats fed with apple phytochemi-
cals were reduced as result of  apple intake. There were 
50% fewer aberrant crypts observed compared to the 
non-fed group. The authors predicted that this effect is 
extendable to humans who are consuming two apples per 
day. This would provide a sufficient amount of  procyani-
din (4-10 mg/kg body weight) to attain similar results in 
humans. 
BERRY JUICE
The botanical name of  chokeberry is Aronia meloncarpa 
and that of  bilberry is Vaccinium myrtillus. These fruits are 
grown in North America, Europe, Asia, and Africa. An-
thocyanin-rich extracts (AREs) derived from berries are 
prepared by certain quantization methods to maximize 
pigment recovery. The berry extracts contain anthocy-
anin, β-carotene, a carotenoid and tangeretin, a flavonoid. 
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tion. In the presence of  the chokeberry extract, NCM460 
cells, which are epithelial cells from normal colon, were 
found to grow normally[34]. 
Cell cycle progression is regulated by the interaction 
between cyclins and cyclin-dependent kinases (CDKs). 
Cyclin-dependent kinase inhibitors (CDKIs) negatively 
regulate the activity of  CDKs and play an important role 
in controlling cell cycle progression. CDKIs, such as 
p21WAF1 and p27KIP1, bind to cyclin-CDK complexes 
and halt the G1 phase of  the cell cycle. HT29 cell per-
centage after exposure to chokeberry was increased, and 
a block in the cell cycle checkpoint in the G1/G0 phase 
was observed[35]. Depending on the time of  exposure 
to AREs, an increase in p21WAF1 and p27KIP1 gene 
expression was in agreement with ARE-induced G1/G0 
cell cycle arrest. Phytochemicals, such as β-carotene 
and tangeretin, mediate cell cycle arrest in colon cancer 
cells by upregulating the expression of  p27KIP1 and 
p21WAF1, which can block the cell cycle by inhibiting 
both G1 and G2-phase cyclin-CDK complexes[35]. Al-
though blocking of  cell cycle at both G1/G0 and G2/M 
phases after exposure of  HT29 cells to chokeberry AREs 
was demonstrated, chokeberry AREs neither affected the 
cell cycle nor altered the expression of  cell cycle genes 
in normal colon cells. This evidence supports the notion 
that AREs prevent cancer cell growth through the inhibi-
tion of  cell cycle events.
Cyclooxygenase (COX) enzymes are involved in pros-
taglandin formation through the catalysis of  arachidonic 
acid oxygenation. Carcinomas and colorectal adenomas 
show an increase in COX-2 mRNA compared to normal 
mucosa[36]. COX-2 is also upregulated or induced in re-
sponse to inflammation, whereas COX-1 is expressed in 
all body tissues and performs a “housekeeping” role. In 
the NCM460 cell line, derived from normal colon mucosa, 
expression of  COX-2 is low in comparison to the consti-
tutively expressed COX-1. In contrast, high expression of  
COX-2 is seen in HT29 cells. Hence, chemoprevention of  
colon cancer is possible by inhibiting COX genes. A plau-
sible method is to use non-steroidal anti-inflammatory 
drugs to inhibit the COX-2 enzyme, thereby delaying or 
preventing cancer of  the colon. Recent studies revealed 
that anthocyanin fractions isolated from various ber-
ries show an inhibitory effect on COX enzyme activities 
in vitro[37]. Seeram et al[37] demonstrated that COX-1 and 
COX-2 enzymes were inactivated by cyanidin-3-rutinoside 
and cyanidin-3-glucosylrutinoside anthocyanins extracted 
from sweet cherries and raspberries. The basal level of  
COX-2 mRNA after exposure to chokeberry ARE was 
not altered in NCM460 cells. In contrast, the levels of  
COX-2 mRNA derived from colon adenocarcinoma were 
high. It is supposed that the difference in growth response 
of  the two cell lines after exposure to chokeberry extracts 
may be through a COX-dependent mechanism, as evi-
denced by the variable expression levels of  COX enzymes. 
However, further experimentation revealed that with an 
increase in chokeberry extract exposure time, there was 
an increase in COX-2 expression levels in HT29 cells. 
The cells treated with ARE showed an increase in COX-2 
protein and prostaglandin E2, indicating that growth in-
hibition was not ascribed to COX-2 inhibition. HT29 cell 
growth inhibition after exposure to chokeberry AREs is 
not mediated through the suppression of  COX-2 activ-
ity, though the activity of  COX enzymes was inhibited 
by anthocyanins in vitro. It may be a COX-independent 
growth inhibition. A COX-independent effect in growth 
was also observed in colorectal cancer cells treated with 
celecoxib[37]. Furthermore, the mechanism of  growth 
inhibition may involve the NF-κB pathway inhibition, 
peroxisome proliferator-activated receptors, or expression 
of  the cell cycle genes[38]. Thus, it can be concluded that 
chokeberry AREs upregulated p21WAF1 and p27KIP1 
and downregulated cyclin A and cyclin B1 to inhibit colon 
carcinoma cell growth, with very limited effects on the 
growth of  normal colon cells. This ensures that AREs can 
be used for treating human colorectal cancers without af-
fecting normal cells significantly.
In vivo effect of berry juice on colon cancer
Hagiwara et al[33] demonstrated that rats fed with purple 
corn color extract, which is rich in anthocyanin, showed 
a decrease in the prevalence of  aberrant crypt foci and 
early colon cancer lesions. This experiment demonstrates 
that 2-amino-1-methyl-6-phenylimidazol(4,5-b) pyridine-
induced colon carcinogenesis was abated by anthocyanin-
rich fractions[33]. In another report, oral administration of  
lyophilized black raspberries containing anthocyanins to 
rodents produced inhibitory effects on colorectal cancer 
and/or polyp tissue. In addition, biomarkers of  prolifera-
tion and angiogenesis were significantly reduced by the 
berry treatment, while apoptosis was greatly enhanced[39].
Mirtocyan is an anthocyanin-rich standardized bilber-
ry extract. It causes pharmacodynamic changes commen-
surate with colorectal cancer chemopreventive efficacy 
and generates measurable anthocyanin levels in urine, 
blood and target tissues. Low doses of  mirtocyan showed 
a significant reduction in the levels of  circulating insulin-
like growth factor-1, which possesses a procarcinogenic 
property[40]. Hence, further studies on the pharmacody-
namic effects of  bilberry anthocyanins at various doses 
are essential to demonstrate them as potential colorectal 
cancer chemopreventive agents.
CONCLUSION
The objectives of  this review were to document the 
chemopreventive effects of  apple and berry fruit juices 
against colon cancer and to discuss preclinical and clinical 
effects of  these juices. Furthermore, bioavailability and 
metabolism of  these fruit extracts were highlighted. Sum-
maries of  in vitro and in vivo studies of  apple and berry 
juice against colon cancer represented in Tables 1 and 2, 
respectively.
This review justifies the need for additional preclinical 
studies with these juices and extracts. In order to bolster 
the anticancer effect of  these juices/extracts against co-
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Table 1  In vitro  and in vivo  effects of apple extracts against colon cancer
Apple juice and its 
Components
Models 
(cell line/animal)
Observation/result Ref. 
Apple extracts HT29 and LT97 colon 
adenoma cell line
SCFA increased 1.5 fold in fermented samples [19]
SCFA stimulates apoptosis, differentiation and growth arrest
Composite mixture of apple 
extracts
HT29 cells PKC activity was decreased by 50% after 24 h exposure of 403 mg/mL [17]
Upstream signaling elements targeted after longer duration of exposure
Polyphenolic mixtures from 
cider, table apples and apple 
pomace;
Phenolics such as phlorizin, 
rutin, quercetin and phloretin
Caco-2 cells and HT29 
colonic cell lines
Reduced oxidative damage [14]
Reduced the presence of butyl hydroperoxide-induced ROS
Caco-2 cells Induction of p450 1A1 expression and inhibition of catalytic activity of the enzyme
Anthocyanidin-rich fraction of 
apple juice
HT29 and MCF-7 breast 
cancer cell line
Significant dose reduction in HT29 cells and not in MCF-7 cells [15]
MCF-7 cells are less responsive to extract exposure
Procyanidins of apple juice 
(polymeric polyphenols)
SW620 
adenocarcinoma-
derived metastatic cells 
of colon cancer 
Dose-dependent inhibition of cell growth [16] 
50% of inhibition at 45 mg/mL and total inhibition at 70 mg/mL
Downregulation of signaling pathway such as cell proliferation and differentiation, PKC 
and enzymes involved in polyamine biosynthesis and stimulation of catabolism
Increased number of apoptotic cells and interruption in cell cycle 
Apple phytochemicals Rats injected with 
azoxymethane
Reduction in preneoplastic lesions and 50% fewer aberrant crypts 
Apple juice extract;
Synthetic mixture, isolated 
components
HT29 cells Decreased growth rate efficiently for 24, 48 and 72 h [18] 
Increased the expression of genes which include phase-2 enzymes, including glutathone-
s-transferases and sulfotransferases, which are involved in chemoprevention
Growth rate inhibition was less efficient comparatively
Lesser effectiveness than either mixture
Two preparation methods of 
apple juice: clear and cloudy 
(higher content of pectin and 
procyanidin)
Rat model 
(induced with 
1,2-dimethylhydrazine) 
Protection from dimethylhydrazine-induced genotoxic damage [20] 
Important markers were reduced including decreased number of large aberrant crypt 
foci in the distal colon, reduced DNA damage and reduced hyper-proliferation
Polyphenolic-rich extracts Rat model 
(induced with 
1,2-dimethylhydrazine)
Juice fractions were found to be more effective in protecting from damage compared to 
isolated fractions
[21]
PKC: Protein kinase C; ROS: Reactive oxygen species; SCFA: Short-chain fatty acids.
Table 2  In vitro  and in vivo  effects of berry extracts against colon cancer 
Berry juice and its 
Components
 Models 
(cell line/animal)
Observation/result Ref. 
Anthocyanin fractions of berry 
juice
HCT-15 cells Inhibited growth of human intestinal carcinoma cells [31,33] 
HCT-116 cells Inhibited the growth of colon cancer cells
Chokeberry ARE HT29 cells Percentage of cells increased and blockade in G1/G0 phase of cell cycle [32,33] 
Increased expression of p21WAF1 and p27KIP1 genes 
Decreased percentage of cells in S phase indicating that cells moved to G2/M phase [35]
Predominant anthocyanin: 
cyanidin-3-galactoside
HT29 cells 65% growth inhibition after 24 h exposure [34] 
High cell viability observed indicating cytostatic inhibition 
Inactivation of COX-1 and COX-2 enzymes
Anthocyanins 
(cyanidin-3-glucosylrutinoside 
and cyanidin-3-rutinoside)
HT29 cells Growth inhibition of cells may occur in a COX-independent manner [37]
Phytochemicals of berry juice; 
Carotenoid (β-carotene) and 
flavonoid (tangeritin)
HT29 cells Upregulation of p21WAF1 and p27KIP1 expression [35]
p21WAF1 CDKI blocks G1 and G2 phase cyclin-CDK complexes
Anthocyanin-rich purple corn 
color of berry juice
Rats injected with PhIP Decrease in incidence of early colon cancer lesions, decrease in aberrant crypt foci 
and a protective effect against PhIP-induced colon carcinogenesis
[33] 
Anthocyanin-rich black 
raspberries
Rodents with colorectal 
cancer/polyp tissue
Biomarkers of proliferation and angiogenesis were significantly reduced while 
apoptosis of cancer cells was enhanced
Mirtocyan of bilberry extract Patients with colorectal 
adenocarcinoma 
and colorectal liver 
metastases
Significant reduction in IGF-1 levels thereby reducing carcinogenesis [40] 
ARE: Anthocyanin-rich extract; CDK: Cyclin-dependent kinase; CDKI: CDK inhibitor; COX: Cyclooxygenase; IGF-1: Insulin-like growth factor-1; PhIP: 
2-amino-1-methyl-6-phenylimidazol(4,5-b) pyridine.
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lon cancer in vitro, experiments using additional cell lines 
are crucial. Further, in vivo studies using ApcMin/+ mouse 
models may provide some valuable insights about the 
mechanism of  action of  these juices. The purpose of  this 
work is to highlight the importance of  establishing clinical 
trials in human subjects. It will be noteworthy to perform 
clinical trials in patients with colon cancer, in which the 
effects produced by the oral consumption of  these fruit 
juices can be outlined. For instance, colorectal cancer pa-
tients must be administered a measured quantity of  fruit 
juices on a regular basis for a specific duration of  time. 
Then, chemopreventive effects produced by these fruit 
juices against colon cancer may be documented. Hence, 
conducting human clinical trials may validate the potency 
of  these fruit juices in the fight against colon cancer.
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